Stefan Heller
Director/Board Member at Nerio Therapeutics, Inc.
Profile
Stefan Heller is currently the Deputy Chairman at Otto Eckart GmbH, Director at Avelas Biosciences, Inc., and Director at Nerio Therapeutics, Inc. He is also a Professor at Stanford University School of Medicine and an Associate Member at the Institute For Stem Cell Biology & Regenerative Medicine.
In the past, he served as an Independent Director at Janux Therapeutics, Inc. from 2018 to 2022 and was a Member at Harvard Medical School from 2000 to 2005.
He holds a doctorate degree from The Johannes Gutenberg University of Mainz.
Stefan Heller active positions
| Companies | Position | Start |
|---|---|---|
Nerio Therapeutics, Inc.
 Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Director/Board Member | - |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Director/Board Member | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
| Institute For Stem Cell Biology & Regenerative Medicine | Corporate Officer/Principal | - |
| Stanford University | Corporate Officer/Principal | 01/10/2005 |
Otto Eckart GmbH
 Otto Eckart GmbH Other Consumer ServicesConsumer Services Otto Eckart GmbH operates museums. The private company is based in Munich, Germany. The German company was founded in 1996 by Otto Eckart. The CEO is Martin Schütze. | Director/Board Member | - |
Former positions of Stefan Heller
| Companies | Position | End |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Director/Board Member | 22/09/2022 |
| Harvard Medical School | Corporate Officer/Principal | 01/01/2005 |
Training of Stefan Heller
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| JANUX THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Nerio Therapeutics, Inc.
Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Commercial Services |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |
| Institute For Stem Cell Biology & Regenerative Medicine | |
Otto Eckart GmbH
Otto Eckart GmbH Other Consumer ServicesConsumer Services Otto Eckart GmbH operates museums. The private company is based in Munich, Germany. The German company was founded in 1996 by Otto Eckart. The CEO is Martin Schütze. | Consumer Services |
- Stock Market
- Insiders
- Stefan Heller
